These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7507049)

  • 1. Finasteride, MSD: Innovation in the Management of Benign Prostatic Hyperplasia. Proceedings of a symposium. Seville, Spain, November 3, 1991.
    Eur Urol; 1994; 25 Suppl 1():1-36. PubMed ID: 7507049
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
    Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
    Mazo EB
    Urologiia; 2001; (3):20-2. PubMed ID: 11505535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finasteride and benign prostatic hyperplasia.
    Drug Ther Bull; 1995 Mar; 33(3):19-21. PubMed ID: 7587986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the effectiveness of long-term treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Luk'ianov AE
    Urologiia; 2002; (2):11-3. PubMed ID: 12077812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 9. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
    Federman DG
    Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
    Ammar H; Malani AK; Gupta C
    BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
    Collins GN
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
    [No Abstract]   [Full Text] [Related]  

  • 12. [PSA values before and after finasteride treatment in patients with benign prostatic hypertrophy].
    Trinchieri A; Dell'Orto P
    Arch Ital Urol Androl; 1995 Feb; 67(1):33-5. PubMed ID: 7538385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finasteride to prevent morbidity from benign prostatic hyperplasia.
    Wasson JH
    N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial.
    Guess HA; Heyse JF; Gormley GJ; Stoner E; Oesterling JE
    Urol Clin North Am; 1993 Nov; 20(4):627-36. PubMed ID: 7505970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
    Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
    J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Finasteride in the treatment of benign prostatic hypertrophy].
    Ekman P
    J Urol (Paris); 1993; 99(6):299-302. PubMed ID: 7516372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
    Taneja S
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.
    Stoner E
    Arch Intern Med; 1994 Jan; 154(1):83-8. PubMed ID: 7505563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?
    Alcántara-Montero A; Brenes-Bermúdez FJ
    Actas Urol Esp; 2016 May; 40(4):268-9. PubMed ID: 26774534
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating benign prostatic hyperplasia with medications.
    Long K; Long R
    Nurse Pract Forum; 1994 Sep; 5(3):126-7. PubMed ID: 7524871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.